Site Search
Search Results
Connecticut House Votes to Improve Access to Biomarker Testing
HARTFORD – May 9, 2025 – Yesterday, the Connecticut House voted in unanimous support of legislation that would ensure biomarker testing is covered by state regulated insurance plans, including Medicaid, when supported by scientific and medical evidence. The goal of the ... a statement from Bryte Johnson, government relations director for the American Cancer Society Cancer Action Network (ACS CAN) in Connecticut: “Biomarker testing is essential to high-quality, personalized care for many conditions and can be a real gamechanger for many patients, but ...
Lamont Signs into Law Legislation to Remove Barriers to Biomarker Testing
HARTFORD – Yesterday, Gov. Ned Lamont signed into law S.B. 307 An Act Concerning Medicaid Coverage of Biomarker Testing . This legislation will increase Connecticut Medicaid (HUSKY Health) coverage of biomarker testing, a form of precision medicine that enables patients to receive treatments personalized to their specific disease. The ...
Cancer Survivors Convene in Hartford, Urge Lawmakers to Expand Access to Biomarker Testing
HARTFORD – May 9, 2025 – Yesterday, the Connecticut House voted in unanimous support of legislation that would ensure biomarker testing is covered by state regulated insurance plans, including Medicaid, when supported by scientific and medical evidence. The goal of the ... a statement from Bryte Johnson, government relations director for the American Cancer Society Cancer Action Network (ACS CAN) in Connecticut: “Biomarker testing is essential to high-quality, personalized care for many conditions and can be a real gamechanger for many patients, but ...
Cancer Survivors Convene in Hartford, Urge Lawmakers to Expand Access to Biomarker Testing
... diseases like cancer. With this in mind, the volunteers asked lawmakers to improve private insurance coverage of comprehensive cutting edge biomarker testing across all communities. Last year, the legislature acted to ensure such access for Medicaid enrollees, but private insurance companies were not included. Because insurance coverage of biomarker testing has not kept pace with the speed of medical innovation, communities in Connecticut are facing significant disparities in who is ...
Legislature Prioritizing Removing Barriers to Precision Treatments
HARTFORD, CT – Legislation has been introduced, Senate Bill 307, that would ensure biomarker testing, a game changer in the fight against cancer and an essential step in accessing precision medicine treatments, is covered by Medicaid. Biomarker testing and precision medicine are helping extend and improve lives by tailoring care and treatment to a person’s specific type of ...